期刊
EXPERIMENTAL BIOLOGY AND MEDICINE
卷 236, 期 6, 页码 658-671出版社
SAGE PUBLICATIONS LTD
DOI: 10.1258/ebm.2011.011028
关键词
cancer-related symptoms; cytokines; inflammation; NE-kappa B; nutraceuticals
资金
- National Institutes of Health (NIH) [CA-16 672, CA-124787-01A2]
- Center for Targeted Therapy of MD Anderson Cancer Center
Cancer is a disease characterized by dysregulation of multiple genes and is associated with symptoms such as cachexia, anorexia, fatigue, depression, neuropathic pain, anxiety, cognitive impairment, sleep disorders and delirium (acute confusion state) in medically ill patients. These symptoms are caused by either the cancer itself or the cancer treatment. During the past decade, increasing evidence has shown that the dysregulation of inflammatory pathways contributes to the expression of these symptoms. Cancer patients have been found to have higher levels of proinflammatory cytokines such as interleukin-6. The nuclear factor (NF)-kappa B is a major mediator of inflammatory pathways. Therefore, anti-inflammatory agents that can modulate the NE-kappa B activation and inflammatory pathways may have potential in improving cancer-related symptoms in patients. Because of their multitargeting properties, low cost, low toxicity and immediate availability, natural agents have gained considerable attention for prevention and treatment of cancer-related symptoms. How NF-kappa B and inflammatory pathways contribute to cancer-related symptoms is the focus of this review. We will also discuss how nutritional agents such as curcumin, genistein, resveratrol, epigallocatechin gallate and lycopene can modulate inflammatory pathways and thereby reduce cancer-related symptoms in patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据